MAPK7 Regulates EMT Features and Modulates the Generation of CTCs

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Cancer Research

• Publication date

  2015-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-14-0604PMID 25678598PMCID PMC4433453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

  2014cited by this paper
• SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013influential reference
• MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

  2013cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• To differentiate or not — routes towards metastasis

  2012cited by this paper
• Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer

  2012influential reference
• Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?

  2011cited by this paper
• Cancer theory faces doubts

  2011cited by this paper
• The ins and outs of the epithelial to mesenchymal transition in health and disease.

  2011cited by this paper
• ERK5 signalling in prostate cancer promotes an invasive phenotype

  2011cited by this paper
• Defining MAP3Kinases Required for MDA-MB-231 Cell Tumor Growth and Metastasis

  2011cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cited by this paper
• A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.

  2010cited by this paper
• Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

  2010cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Key signalling nodes in mammary gland development and cancer: Myc

  2009cited by this paper
• Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target

  2009cited by this paper
• Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.

  2008cited by this paper
• Direct evidence for epithelial-mesenchymal transitions in breast cancer.

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

  2008cited by this paper
• Detection, clinical relevance and specific biological properties of disseminating tumour cells

  2008cited by this paper
• Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).

  2008cited by this paper
• Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype

  2008influential reference
• Erk5 controls Slug expression and keratinocyte activation during wound healing.

  2008cited by this paper
• Highly parallel identification of essential genes in cancer cells

  2008cited by this paper
• A probability-based approach for the analysis of large-scale RNAi screens

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

  2006cited by this paper
• Gene expression profiling of breast cell lines identifies potential new basal markers

  2006cited by this paper
• A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

  2006cited by this paper
• Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

  2006cited by this paper
• Extracellular signal-regulated kinase (ERK) 5 is necessary and sufficient to specify cortical neuronal fate.

  2006cited by this paper
• A genetic screen for candidate tumor suppressors identifies REST.

  2005cited by this paper
• The Snail genes as inducers of cell movement and survival: implications in development and cancer

  2005cited by this paper
• Dissecting cancer pathways and vulnerabilities with RNAi.

  2005cited by this paper
• Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• Multifunctional role of Erk5 in multiple myeloma.

  2005cited by this paper
• Breast cell invasive potential relates to the myoepithelial phenotype

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Activation of the Ras/Mitogen-Activated Protein Kinase Pathway by Kinase-Defective Epidermal Growth Factor Receptors Results in Cell Survival but Not Proliferation

  1998cited by this paper

• Dissecting Context-Specific Effects of ERK5 Signaling in Triple-Negative Breast Cancer

  2026cites this paper
• Unlocking the Therapeutic Potential of Alisertib in Breast Cancer: An In-Depth Exploration of Molecular Targets Using Network Pharmacology and Gene Expression Network

  2025cites this paper
• Fluorescence Assisted Investigation of ERK1/2 Signaling in the Regulation of ATG3 and ATG5 Under Glutamine and Glucose Deprivation in Breast Cancer Cells.

  2025cites this paper
• Integrative Machine Learning Model for Overall Survival Prediction in Breast Cancer Using Clinical and Transcriptomic Data

  2025cites this paper
• Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes

  2024cites this paper
• Bone and Extracellular Signal-Related Kinase 5 (ERK5)

  2024cites this paper
• Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classification

  2023cites this paper
• Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.

  2023cites this paper
• Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?

  2022cites this paper
• PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice

  2022cites this paper
• Clinical Significance and Regulation of ERK5 Expression and Function in Cancer

  2022cites this paper
• A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer

  2021influential citation
• Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling

  2021cites this paper
• The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion

  2021cites this paper
• The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF–MEK1/2–ERK1/2 Pathway

  2021influential citation
• Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

  2021cites this paper
• BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition.

  2020cites this paper
• MicroRNA-143 Regulates Proliferative and apoptotic potential of pituitary tumor cell via direct targeting on MAPK7 gene

  2020cites this paper
• ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

  2020cites this paper
• Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer

  2020cites this paper
• Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner

  2020cites this paper
• Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.

  2020cites this paper
• MEK5/ERK5 activation regulates colon cancer stem-like cell properties

  2019cites this paper
• The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.

  2019cites this paper
• Impact of ERK5 on the Hallmarks of Cancer

  2019cites this paper
• Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer

  2019cites this paper
• Regulation of the MAPK signaling pathway by miR-421-5p in rats under light pollution

  2018cites this paper
• A kinome-wide high-content siRNA screen identifies MEK5–ERK5 signaling as critical for breast cancer cell EMT and metastasis

  2018cites this paper
• Capn4 promotes colorectal cancer cell proliferation by increasing MAPK7 through activation of the Wnt/&bgr;‐Catenin pathway

  2018cites this paper
• MEK 5-ERK 5 Signaling in Cancer : Implications for Targeted Therapy

  2018influential citation
• Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program

  2018cites this paper
• Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer

  2018cites this paper
• MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7.

  2017cites this paper
• Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.

  2017cites this paper
• The Landscape of Circulating Tumor Cell Research in the Context of Epithelial-Mesenchymal Transition

  2017cites this paper
• Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart Algorithm

  2017cites this paper
• Mitogen-activated Protein Kinase 7 Promotes Cell Proliferation, Migration and Invasion in SOSP-M Human Osteosarcoma Cell Line

  2017cites this paper
• DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma

  2017cites this paper
• Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition

  2017cites this paper
• Oncogenic signaling of MEK5-ERK5.

  2017cites this paper
• Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks

  2016cites this paper
• Microfluidics for High-Throughput Cellular Isolation and Analysis in Biomedicine

  2016cites this paper
• Circulating tumor cells in breast cancer†

  2016cites this paper
• ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization

  2016cites this paper
• Visualizing Epithelial-Mesenchymal Transition Using the Chromobody Technology.

  2016cites this paper
• The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.

  2016cites this paper
• The MEK 5 / ERK 5 signalling pathway in cancer : a promising novel therapeutic target

  2016cites this paper
• International Journal of Molecular Sciences the Significance of Epithelial-to-mesenchymal Transition for Circulating Tumor Cells

  year unknowncites this paper